DCEG investigators developed models to estimate a current or former smoker’s risk of developing lung cancer and their gain in life-expectancy from lung cancer screening, freely available online at ScreenLC.com. These models included:
- Lung Cancer Risk Assessment Tool (LCRAT)
- Lung Cancer Death Risk Assessment Tool (LCDRAT)
- Life-Years from Screening-CT (LYFS-CT)
They are recommended for use by the American College of Chest Physicians.
University of Utah investigators implemented the models as a clinical decision-making tool within Epic Electronic Health Records, known as Decision Precision+ (DP+). In a randomized trial, use of DP+ increased uptake of low-dose CT screening for lung cancer 5-fold (from 4% to 20%). DP+ is available to health systems using Epic for free, with implementation support provided by a grant from the Agency for Health Research and Quality.
Website
Link to ScreenLC web based tool
Support
Email: Li Cheung
References
- Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK. Development and validation of risk models to select ever-smokers for CT lung cancer screening. JAMA. 2016.
- Cheung LC, Berg CD, Castle PE, Katki HA, Chaturvedi AK. Life-gained versus risk-based selection of smokers for lung cancer screening. Ann Intern Med. 2019.